Business Ideas

Bilcare weakens despite GDR issue

Bilcare ended at Rs 512, lower by Rs 2 or 0.3%, on the BSE. - M&M slips on plans of aviation extention - Sensex breaks four day winning streak - Birla Shloka Edutech fixes FPO price band at Rs 45-50 - Markets end weak - Weakness persists - Sensex exhibit weakness The stock opened at Rs 520 and saw a high of Rs 530 and a low of Rs 511 during the day. The counter clocked volumes of 0.30 lakh shares as against the two-week average of 0.64 lakh shares. -----------------------------------------------------------------------------------------------------------------(Updated at 1019am) Pharma Packaging firm Bilcare firm on collecting $35mn through global depository receipts (GDR). The stock opened at Rs 520 and soared to a high of Rs 529. The scrip is now trading at Rs 524, up 2% from its previous close. The counter clocked volumes of 6,758 shares on the BSE. The company opened its GDR issue on 6th January through which it intends to raise around Rs 160 crore, for subscription. The offer will remain open for a period of seven days.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Pricewaterhouse approaches Delhi HC against govt action
The Delhi-based franchise of audit firm PricewaterhouseCoopers today approached the Delhi High Court seeking quashing of proceedings initiated against it by the government in the aftermath of Satyam scam.
Popular Articles

Cash for OMCs to cut losses
The Centre has indicated that it would consider giving direct cash subsidy to state-owned oil marketing companies this year, instead of bonds, to compensate them for selling cooking fuel at lower than market price.

Essar, Shell extend talks on refineries' sale
Exclusive talks between Essar Oil and Royal Dutch Shell over the sale of three European refineries — Heide and Harburg in Germany and Stanlow in Britain — will continue for an unspecified period beyond today’s earlier deadline, Essar Oil said in an emailed statement.